Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care
| Autor: | Lynda Roe, David C. Young, Stephanie M Heuser, Justin Moss, Jeffery T. Zobell |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Cystic Fibrosis Medication Therapy Management education Pharmacist Medication adherence Pharmacy Pharmacists Limited access 03 medical and health sciences 0302 clinical medicine Professional Role Ambulatory care 030225 pediatrics Medication therapy management Outpatients medicine media_common.cataloged_instance Humans Prior authorization media_common business.industry 030228 respiratory system Family medicine Pharmaceutical Services Pediatrics Perinatology and Child Health business Pharmacy technician |
| Zdroj: | Pediatric pulmonologyREFERENCES. 56(6) |
| ISSN: | 1099-0496 |
| Popis: | Cystic fibrosis (CF) patients utilize an average of 10 (±5) medications per day. Given the complexity of the medication regimen, the CF Foundation (CFF) recommends pharmacists as members of the CF care team. The areas of pharmacy services have been identified in the literature. "Limited access pharmacists" are consulted to answer questions, assist in evaluating serum drug concentrations, provide medication education, and monitoring for drug-drug interactions. Reduction in hospital length of stay has been shown through this collaboration. "Full access pharmacists" provide comprehensive medication therapy management resulting in medication adherence and access improvements, sustainability of treatments, improved provider communication, reduced medication errors and costs, expedited medication refill authorization, increased utilization of respiratory therapists, enhanced discussion of medications with CF team members, and reduction in the number of pharmacies utilized by patients to fill CF medications. An integrated CF pharmacy team are essential members of the multidisciplinary CF care team that have been shown to improvement in CF medication access, increases in body weight and body mass index, reduction in prior authorization submission times, reduction in medication delivery times, expedited medication refill authorizations, increased collaboration with respiratory therapists, augmented discussion of medication with CF team members, and reduction in the number of pharmacies utilized by CF patients. There is a need to further evaluate the impact of outpatient CF pharmacy services due to the improvements in the care on patients and families affected by CF, and as the number of CFF-accredited care centers integrate CF pharmacy teams throughout the country increases. This article is protected by copyright. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text